News >

Improved OS Data Signal New Era With Immunotherapy in Small Cell Lung Cancer

Jessica Hergert
Published: Tuesday, Nov 19, 2019

Lawrence E. Feldman, MD, a professor of clinical medicine at the University of Illinois Cancer Center

Lawrence E. Feldman, MD
After decades of minimal progress, recent regulatory updates with checkpoint inhibitors have sparked excitement in extensive-stage small cell lung cancer (ES-SCLC) treatment, said Lawrence E. Feldman, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication